|
US20080070981A1
(en)
|
2000-02-23 |
2008-03-20 |
Henryk Borowy-Borowski |
Water-soluble compositions of bioactive lipophilic compounds
|
|
PE20010306A1
(es)
|
1999-07-02 |
2001-03-29 |
Agouron Pharma |
Compuestos de indazol y composiciones farmaceuticas que los contienen utiles para la inhibicion de proteina kinasa
|
|
GB0018891D0
(en)
|
2000-08-01 |
2000-09-20 |
Novartis Ag |
Organic compounds
|
|
JP2004531238A
(ja)
|
2001-02-26 |
2004-10-14 |
ファーマ パシフィック プロプライエタリー リミテッド |
インターフェロン−アルファ誘導遺伝子
|
|
AU2003281200A1
(en)
|
2002-07-03 |
2004-01-23 |
Tasuku Honjo |
Immunopotentiating compositions
|
|
CN101899114A
(zh)
|
2002-12-23 |
2010-12-01 |
惠氏公司 |
抗pd-1抗体及其用途
|
|
US7563869B2
(en)
|
2003-01-23 |
2009-07-21 |
Ono Pharmaceutical Co., Ltd. |
Substance specific to human PD-1
|
|
DK2439273T3
(da)
|
2005-05-09 |
2019-06-03 |
Ono Pharmaceutical Co |
Humane monoklonale antistoffer til programmeret død-1(pd-1) og fremgangsmåder til behandling af cancer ved anvendelse af anti-pd-1- antistoffer alene eller i kombination med andre immunterapeutika
|
|
US8367065B2
(en)
|
2006-09-15 |
2013-02-05 |
Enzon Pharmaceuticals, Inc. |
Targeted polymeric prodrugs containing multifunctional linkers
|
|
BR122017025062B8
(pt)
|
2007-06-18 |
2021-07-27 |
Merck Sharp & Dohme |
anticorpo monoclonal ou fragmento de anticorpo para o receptor de morte programada humano pd-1, polinucleotídeo e composição compreendendo o referido anticorpo ou fragmento
|
|
CN101784565B
(zh)
|
2007-06-25 |
2014-12-10 |
恩多塞特公司 |
含有亲水性间隔区接头的共轭物
|
|
US8603474B2
(en)
|
2008-01-29 |
2013-12-10 |
Ludwig Institute For Cancer Research, Ltd. |
Membrane transporter NaPi2b (SCL34A1) epitope for antibody therapy, antibodies directed thereto, and target for cancer therapy
|
|
EP2262837A4
(en)
|
2008-03-12 |
2011-04-06 |
Merck Sharp & Dohme |
PD-1 BINDING PROTEINS
|
|
JP2012500855A
(ja)
|
2008-08-25 |
2012-01-12 |
アンプリミューン、インコーポレーテッド |
Ｐｄ−１アンタゴニストおよび感染性疾患を処置するための方法
|
|
US8552154B2
(en)
|
2008-09-26 |
2013-10-08 |
Emory University |
Anti-PD-L1 antibodies and uses therefor
|
|
EP3255060A1
(en)
|
2008-12-09 |
2017-12-13 |
F. Hoffmann-La Roche AG |
Anti-pd-l1 antibodies and their use to enhance t-cell function
|
|
WO2011066342A2
(en)
|
2009-11-24 |
2011-06-03 |
Amplimmune, Inc. |
Simultaneous inhibition of pd-l1/pd-l2
|
|
MX368257B
(es)
|
2011-08-01 |
2019-09-26 |
Genentech Inc |
Antagonistas de unión al eje pd-1e inhibidores de mek y sus usos en el tratamiento de cáncer.
|
|
BR112015008365A2
(pt)
|
2012-10-16 |
2017-07-04 |
Endocyte Inc |
composto da fórmula b-l(d)x, ou um sal farmaceuticamente aceitável do mesmo, composição farmacêutica, uso de um composto, composição de forma de dosagem unitária ou dose unitária, composição para tratar um câncer em um paciente, e método para tratar um câncer em um paciente
|
|
US9695212B2
(en)
|
2012-12-13 |
2017-07-04 |
Aduro Biotech, Inc. |
Compositions comprising cyclic purine dinucleotides having defined stereochemistries and methods for their preparation and use
|
|
PE20160080A1
(es)
|
2013-05-18 |
2016-02-21 |
Aduro Biotech Inc |
Composiciones y metodos para activar la senalizacion que depende del estimulador del gen de interferon
|
|
WO2014189806A1
(en)
|
2013-05-18 |
2014-11-27 |
Aduro Biotech, Inc. |
Compositions and methods for inhibiting "stimulator of interferon gene" dependent signalling
|
|
NZ758049A
(en)
|
2013-10-15 |
2024-03-22 |
Seagen Inc |
Pegylated drug-linkers for improved ligand-drug conjugate pharmacokinetics
|
|
HRP20190888T8
(hr)
*
|
2014-04-25 |
2019-10-04 |
Pierre Fabre Médicament |
Konjugat antitijela za igf-1r i lijeka i njegova upotreba u liječenju karcinoma
|
|
CR20160564A
(es)
|
2014-06-04 |
2017-01-20 |
Glaxosmithkline Ip Dev Ltd |
Dinucleótidos cíclicos como moduladores de sting
|
|
TWI695011B
(zh)
|
2014-06-18 |
2020-06-01 |
美商梅爾莎納醫療公司 |
抗ｈｅｒ２表位之單株抗體及其使用之方法
|
|
EP3546473B1
(en)
|
2014-12-16 |
2025-12-10 |
Kayla Therapeutics |
Fluorinated cyclic [(2',5')p(3',5')p]-dinucleotides for cytokine induction
|
|
WO2016096577A1
(en)
|
2014-12-16 |
2016-06-23 |
Invivogen |
Combined use of a chemotherapeutic agent and a cyclic dinucleotide for cancer treatment
|
|
GB201501462D0
(en)
|
2015-01-29 |
2015-03-18 |
Glaxosmithkline Ip Dev Ltd |
Novel compounds
|
|
KR102222186B1
(ko)
|
2015-08-13 |
2021-03-03 |
머크 샤프 앤드 돔 코포레이션 |
Sting 효능제로서 시클릭 디-뉴클레오티드 화합물
|
|
JP2018534295A
(ja)
|
2015-10-28 |
2018-11-22 |
アドゥロ バイオテック，インク． |
「インターフェロン遺伝子刺激因子」依存性シグナル伝達を活性化するための組成物および方法
|
|
CN107849084B
(zh)
|
2015-12-03 |
2021-09-14 |
葛兰素史密斯克莱知识产权发展有限公司 |
作为sting调节剂的环状嘌呤二核苷酸
|
|
US20170158772A1
(en)
*
|
2015-12-07 |
2017-06-08 |
Opi Vi - Ip Holdco Llc |
Compositions of antibody construct - agonist conjugates and methods of use thereof
|
|
DE212016000029U1
(de)
|
2015-12-07 |
2017-07-30 |
Opi Vi - Ip Holdco Llc |
Zusammensetzungen von Antikörperkonstrukt-Agonist-Konjugaten
|
|
JP7137474B2
(ja)
|
2016-03-15 |
2022-09-14 |
メルサナ セラピューティクス，インコーポレイティド |
ＮａＰｉ２ｂ標的化抗体－薬物コンジュゲート及びその使用方法
|
|
JP2019510802A
(ja)
|
2016-04-07 |
2019-04-18 |
グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッドＧｌａｘｏｓｍｉｔｈｋｌｉｎｅ Ｉｎｔｅｌｌｅｃｔｕａｌ Ｐｒｏｐｅｒｔｙ Ｄｅｖｅｌｏｐｍｅｎｔ Ｌｉｍｉｔｅｄ |
タンパク質調節物質として有用な複素環アミド
|
|
PT3440076T
(pt)
*
|
2016-04-07 |
2022-07-29 |
Glaxosmithkline Ip Dev Ltd |
Amidas heterocíclicas úteis como modeladores de proteína
|
|
US10225009B2
(en)
|
2016-07-01 |
2019-03-05 |
Adtran, Inc. |
Broadband access devices having a radio link
|
|
EP3507367A4
(en)
|
2016-07-05 |
2020-03-25 |
Aduro BioTech, Inc. |
CYCLIC DINUCLEOTID COMPOUNDS WITH INCLUDED NUCLEIC ACIDS AND USES THEREOF
|
|
PT3523287T
(pt)
|
2016-10-04 |
2021-10-06 |
Merck Sharp & Dohme |
Compostos de benzo[b]tiofeno como agonistas de sting
|
|
US11135307B2
(en)
*
|
2016-11-23 |
2021-10-05 |
Mersana Therapeutics, Inc. |
Peptide-containing linkers for antibody-drug conjugates
|
|
US20190336615A1
(en)
|
2017-01-27 |
2019-11-07 |
Silverback Therapeutics, Inc. |
Tumor targeting conjugates and methods of use thereof
|
|
US20180271996A1
(en)
*
|
2017-02-28 |
2018-09-27 |
Mersana Therapeutics, Inc. |
Combination therapies of her2-targeted antibody-drug conjugates
|
|
AR113224A1
(es)
*
|
2017-04-28 |
2020-02-19 |
Novartis Ag |
Conjugados de anticuerpo que comprenden un agonista de sting
|
|
EP3634401A1
(en)
|
2017-06-07 |
2020-04-15 |
Silverback Therapeutics, Inc. |
Antibody construct conjugates
|
|
JP2020530838A
(ja)
|
2017-08-04 |
2020-10-29 |
メルク・シャープ・アンド・ドーム・コーポレーションＭｅｒｃｋ Ｓｈａｒｐ ＆ Ｄｏｈｍｅ Ｃｏｒｐ． |
がん治療のためのベンゾ［ｂ］チオフェンＳＴＩＮＧアゴニスト
|
|
RU2020109328A
(ru)
|
2017-08-04 |
2021-09-06 |
Мерк Шарп И Доум Корп. |
Комбинации антагонистов pd-1 и бензо[b]тиофеновых агонистов sting для лечения рака
|
|
JP7279026B2
(ja)
|
2017-09-20 |
2023-05-22 |
メルサナ セラピューティクス インコーポレイテッド |
Ｎａｐｉ２ｂ標的化療法に対する応答を予測するための組成物および方法
|
|
CA3077337A1
(en)
|
2017-10-05 |
2019-04-11 |
Glaxosmithkline Intellectual Property Development Limited |
Modulators of stimulator of interferon genes (sting)
|
|
EP3691640A1
(en)
*
|
2017-10-05 |
2020-08-12 |
GlaxoSmithKline Intellectual Property Development Limited |
Methods for administering sting agonists
|
|
AU2018344902B2
(en)
|
2017-10-05 |
2021-06-03 |
Glaxosmithkline Intellectual Property Development Limited |
Modulators of stimulator of interferon genes (STING) useful in treating HIV
|
|
WO2019084060A1
(en)
|
2017-10-24 |
2019-05-02 |
Silverback Therapeutics, Inc. |
CONJUGATES AND METHODS OF USE FOR THE SELECTIVE DELIVERY OF IMMUNOMODULATORY AGENTS
|
|
MX2020004691A
(es)
|
2017-11-07 |
2020-08-20 |
Regeneron Pharma |
Enlazadores hidrofilicos para conjugados anticuerpo-farmaco.
|
|
WO2019134707A1
(zh)
|
2018-01-08 |
2019-07-11 |
成都先导药物开发股份有限公司 |
一种免疫调节剂
|
|
CN110016025B
(zh)
|
2018-01-08 |
2021-08-06 |
成都先导药物开发股份有限公司 |
一种免疫调节剂
|
|
JP7326319B2
(ja)
|
2018-04-03 |
2023-08-15 |
メルク・シャープ・アンド・ドーム・エルエルシー |
Ｓｔｉｎｇアゴニストとしてのベンゾチオフェン類及び関連する化合物
|
|
EP3774765A4
(en)
|
2018-04-03 |
2021-12-29 |
Merck Sharp & Dohme Corp. |
Aza-benzothiophene compounds as sting agonists
|
|
JP7570235B2
(ja)
|
2018-05-25 |
2024-10-21 |
インサイト・コーポレイション |
Ｓｔｉｎｇ活性化剤としての三環式複素環式化合物
|
|
US20210353652A1
(en)
|
2018-06-04 |
2021-11-18 |
Trustees Of Tufts College |
Tumor microenvironment-activated drug-binder conjugates, and uses related thereto
|
|
TW202016081A
(zh)
|
2018-06-21 |
2020-05-01 |
英商克拉德夫製藥有限公司 |
人類ｓｔｉｎｇ之小分子調節劑、結合物及治療應用
|
|
US11535633B2
(en)
|
2018-06-28 |
2022-12-27 |
Jiangsu Hengrui Medicine Co., Ltd. |
Fused tricyclic heterocycle compounds and therapeutic uses thereof
|
|
WO2020010451A1
(en)
*
|
2018-07-10 |
2020-01-16 |
Trillium Therapeutics Inc. |
Heteroaromatic-fused imidazolyl amides, compositions and uses thereof as sting agonists
|
|
WO2020028566A1
(en)
|
2018-07-31 |
2020-02-06 |
Incyte Corporation |
Heteroaryl amide compounds as sting activators
|
|
AU2019326633B2
(en)
|
2018-08-24 |
2022-09-08 |
Adlai Nortye Biopharma Co., Ltd. |
High activity sting protein agonist
|
|
CN111655682B
(zh)
|
2018-08-29 |
2024-05-31 |
杭州阿诺生物医药科技有限公司 |
一种高活性sting蛋白激动剂化合物
|
|
MX2021002764A
(es)
|
2018-09-12 |
2021-05-12 |
Silverback Therapeutics Inc |
Composiciones para el tratamiento de enfermedades con conjugados inmunoestimuladores.
|
|
CN110963997A
(zh)
|
2018-09-28 |
2020-04-07 |
四川科伦博泰生物医药股份有限公司 |
杂环酰胺类化合物、包含其的药物组合物及其制备方法和用途
|
|
US20220362253A1
(en)
|
2018-12-06 |
2022-11-17 |
Glaxosmithkline Intellectual Property Development Limited |
Novel pharmaceutical formulation
|
|
WO2020132549A1
(en)
|
2018-12-21 |
2020-06-25 |
Nimbus Titan, Inc. |
Sting heterocycle agonists and uses thereof
|
|
WO2020132566A1
(en)
|
2018-12-21 |
2020-06-25 |
Nimbus Titan, Inc. |
Sting pyrazole agonists and uses thereof
|
|
WO2020132582A1
(en)
*
|
2018-12-21 |
2020-06-25 |
Nimbus Titan, Inc. |
Sting agonists and uses thereof
|
|
CN111393405B
(zh)
|
2019-01-02 |
2022-11-25 |
中国科学院上海药物研究所 |
一类含氟取代的苯并噻吩类化合物及其药物组合物及应用
|
|
CN111393404B
(zh)
|
2019-01-02 |
2023-02-17 |
中国科学院上海药物研究所 |
一类苯并噻吩类化合物及其药物组合物及应用
|
|
WO2020146237A1
(en)
|
2019-01-07 |
2020-07-16 |
Incyte Corporation |
Heteroaryl amide compounds as sting activators
|
|
CN111471056B
(zh)
|
2019-01-23 |
2021-07-02 |
成都先导药物开发股份有限公司 |
一种大环类免疫调节剂
|
|
CN113563313B
(zh)
|
2019-01-31 |
2022-11-04 |
成都先导药物开发股份有限公司 |
一种免疫调节剂
|
|
MX2021010701A
(es)
|
2019-03-05 |
2022-02-21 |
F Star Therapeutics Inc |
Compuestos, composiciones y metodos para el tratamiento de enfermedad.
|
|
BR112021018947A2
(pt)
|
2019-03-28 |
2022-02-08 |
Lupin Ltd |
Compostos macrocíclicos como agonistas de sting
|
|
TW202104214A
(zh)
|
2019-04-05 |
2021-02-01 |
英商葛蘭素史密斯克藍智慧財產發展有限公司 |
化合物
|
|
WO2020214858A1
(en)
|
2019-04-17 |
2020-10-22 |
Avidea Technologies, Inc. |
Compositions and methods of manufacturing star polymers for ligand display and/or drug delivery
|
|
EP3964504A4
(en)
|
2019-04-30 |
2022-12-28 |
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. |
AMINOPYRIMIDINE COMPOUND, METHOD OF PRODUCTION THEREOF AND USE THEREOF
|
|
CN111848573B
(zh)
|
2019-04-30 |
2023-04-07 |
四川科伦博泰生物医药股份有限公司 |
苯并噻吩酰胺类化合物及其制备方法和用途
|
|
WO2020227159A2
(en)
|
2019-05-03 |
2020-11-12 |
Flagship Pioneering Innovations V, Inc. |
Methods of modulating immune activity
|
|
WO2021000770A1
(zh)
|
2019-07-02 |
2021-01-07 |
凯复制药有限公司 |
可增强免疫活性的杂环化合物、其制备方法及其在医药上的应用
|
|
GB201910305D0
(en)
|
2019-07-18 |
2019-09-04 |
Ctxt Pty Ltd |
Compounds
|
|
CR20220029A
(es)
|
2019-07-22 |
2022-03-14 |
Lupin Ltd |
Compuestos macrocíclicos como agonistas de sting y métodos y usos de los mismos
|
|
US20220267364A1
(en)
|
2019-07-25 |
2022-08-25 |
Shanghai Jemincare Pharmaceuticals Co., Ltd. |
Heterocyclic amide compound, preparation method therefor and use thereof
|
|
JP7843695B2
(ja)
|
2019-08-02 |
2026-04-10 |
メルサナ セラピューティクス インコーポレイテッド |
がんの処置用のＳＴＩＮＧ（インターフェロン遺伝子刺激因子）アゴニストとしてのビス－［Ｎ－（（５－カルバモイル）－１Ｈ－ベンゾ［ｄ］イミダゾール－２－イル）－ピラゾール－５－カルボキサミド］誘導体および関連化合物
|
|
EP4069683A1
(en)
|
2019-12-06 |
2022-10-12 |
Mersana Therapeutics, Inc. |
Dimeric compounds as sting agonists
|
|
CN113248475B
(zh)
|
2020-02-11 |
2023-03-17 |
中国科学院上海药物研究所 |
一类杂环取代的苯并咪唑二聚体或其药学上可接受的盐、组合物及其用途
|
|
IL296901A
(en)
|
2020-04-02 |
2022-12-01 |
Mersana Therapeutics Inc |
Antibody-drug conjugates comprising sting agonists
|
|
MX2023008000A
(es)
|
2021-01-04 |
2023-07-13 |
Mersana Therapeutics Inc |
Conjugados de anticuerpo dirigido a b7-h4 y farmaco, y metodos de uso de los mismos.
|
|
CN112898286A
(zh)
|
2021-01-28 |
2021-06-04 |
中国药科大学 |
苯并噻吩类化合物或其可药用的盐、异构体及其制备方法、药物组合物和用途
|
|
JP2025509266A
(ja)
|
2022-03-07 |
2025-04-11 |
メルサナ セラピューティクス インコーポレイテッド |
Ｓｔｉｎｇアゴニストを含む抗体薬物コンジュゲート、組み合わせ、および使用方法
|